Jiang H-Q, Thurnheer M C, Zuercher A W, Boiko N V, Bos N A, Cebra J J
Department of Biology, University of Pennsylvania, Philadelphia, PA 19104-6018, USA.
Vaccine. 2004 Feb 17;22(7):805-11. doi: 10.1016/j.vaccine.2003.11.022.
Although mechanisms operative in the induction and maintenance of specific, adaptive immunity, including 'cognate' B/T interactions, have been extensively studied and defined, we still know little about the mechanisms operative in developing and maintaining B- and T-cell dependent 'natural' immunity. Particularly, we are still rather ignorant concerning gut microbial/gut or systemic APC, T cell and B cell interactions that lead to lymphoid cell mediated 'natural' immunity: specific or broadly reactive, activation via TCR and BCR and/or via other receptors such as the TLR series, and whether T/B interactions are operative at this level? Here we will address: (1) the general role of gut microbes in the development and maintenance of the intestinal, humoral immune system; (2) the general role of gut microbes in the development of B1 cell mediated, 'natural' gut IgA and the dependence of these B1 cells on bystander T cell help; (3) the relative contributions of B1 versus B2 cells to gut 'natural' and specific IgA responses; (4) the role for particular 'normal' gut microbes in the initiation of inflammatory bowel diseases (IBD) in mice with a dysregulated immune system; and (5) the possible roles of gut microbes in facilitating oral tolerance, a mechanism likely operative in forestalling or ameliorating IBD. A central theme of this paper is to attempt to define the specificities of activated, functional CD4+ T cells in the gut for Ags of particular, usually benign gut microbes. We will also consider the still-unresolved issue of whether the contributions of B1-derived IgA in the gut to the 'natural' Ab pool are Ag-selected and driven to proliferation/differentiation or whether the main stimuli are not via BCRs but rather other receptors (TLRs, etc.). The main experimental approach has been to use antigen-free, germ-free, or gnotobiotic (mono- or oligo-associated with precisely known bacterial species) mice.
尽管在诱导和维持特异性适应性免疫过程中发挥作用的机制,包括“同源”B/T细胞相互作用,已得到广泛研究和明确,但我们对在发育和维持B细胞及T细胞依赖性“天然”免疫过程中发挥作用的机制仍知之甚少。特别是,我们对肠道微生物/肠道或全身抗原呈递细胞(APC)、T细胞和B细胞之间的相互作用仍相当无知,这些相互作用导致淋巴细胞介导的“天然”免疫:特异性或广泛反应性,通过T细胞受体(TCR)和B细胞受体(BCR)和/或通过其他受体(如Toll样受体(TLR)系列)激活,以及T/B细胞相互作用是否在此水平上发挥作用?在此,我们将探讨:(1)肠道微生物在肠道体液免疫系统发育和维持中的总体作用;(2)肠道微生物在B1细胞介导的“天然”肠道免疫球蛋白A(IgA)发育中的总体作用以及这些B1细胞对旁观者T细胞辅助的依赖性;(3)B1细胞与B2细胞对肠道“天然”和特异性IgA反应的相对贡献;(4)特定“正常”肠道微生物在免疫系统失调小鼠炎症性肠病(IBD)起始中的作用;以及(5)肠道微生物在促进口服耐受中的可能作用,口服耐受是一种可能在预防或改善IBD中起作用的机制。本文的一个核心主题是试图确定肠道中活化的功能性CD4 + T细胞对特定的、通常为良性的肠道微生物抗原的特异性。我们还将考虑一个尚未解决的问题,即肠道中B1来源的IgA对“天然”抗体库的贡献是抗原选择并驱动增殖/分化,还是主要刺激不是通过BCR而是其他受体(TLR等)。主要的实验方法是使用无抗原、无菌或悉生(与精确已知细菌物种单关联或寡关联)小鼠。